telemedicine bpc 157 BPC-157 Christopher Mendias, PhD, gets four

The FDA strongly recommended that the firm engage a third-party consultant with relevant sterile drug manufacturing expertise to conduct a comprehensive assessment of operations

An increase exceeding 15 bpm suggests excessive sympathetic stimulation and heightens risk for arrhythmias, especially in subjects with underlying conduction abnormalities

Disadvantages: shorter shelf life from date of compounding, you cannot choose your concentration, typically more expensive per milligram

This brings me to my next point

It is associated with thymosin beta-4, a naturally occurring peptide involved in cellular movement and tissue remodeling